糖皮质激素联合特布他林治疗慢阻肺急性加重期的疗效观察

探讨分析糖皮质激索联合特布他林治疗慢阻肺急性加重期的临床效果。方法:对我院2014年1月至2015年5月期间收治的97侧慢阻肺急性加重期患者予以研究,根据治疗方法分为:单一组(n=48)、联合组(n=49)。单一组给予特布他林治疗,联合组给予糖皮质激素与特布他林联合治疗,观察比较两组患者的治疗效果。结果:联合组治疗总有效率为98.0%,显著高于单一组的81.3%,对比差异有统计学意义(P〈0.05)。联合组治疗后的肺功能与单一组比较,差异显著(P〈0.05),有统计学意义。结论:对慢阻肺急性加重期患者实施糖皮质激素与特布他林的联合治疗。能够显著提高治疗有效率,自醣患者肺功能,具有很高的临床选用与普及价值。

Objective: to study the joint analysis of glucocortieoids terbutaline in the treatment of copd in acute aggravating period of clinical effect. Methods: from January 2014 to May 2015 treated 97 cases d copd patients with acute aggravating period of study, according to the treatment methods are divided into: single group ( n = 48 ), a joint group ( n = 49). Single treatment to give terbutaline combined group give glucocorticoid and ter- butaline combined treatment, compare the treatment effect of two groups of patients. Results: the combined treatment group total effective rate was 98.0%, significantly higher than that of single group 81.3%, compare the difference was statistically significant (P 〈 0. 05). Joint group after treatment of lung function compared with a single group, significant difference (P 〈 0. 05 ), with statistical significance. Conclusion: for eopd patients with acute aggravating period of glucocortieoid induced.